Valuation Lundbeck Nasdaq Copenhagen

Stocks

Market Closed - Nasdaq Copenhagen 08:50:00 22/10/2026 pm IST			5-day change	1st Jan Change
48.20 ^DKK	+2.88%		+7.35%	+33.15%

25/09	H. Lundbeck A/S Relocates Its Us Headquarters from Deerfield, Illinois, to Greater Boston, Massachusetts	CI
25/09	Danish Biopharma Group H. Lundbeck to Relocate US Headquarters to Greater Boston	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	25,433	31,719	39,416	41,398	48,555	-	-
Change	-	24.72%	24.27%	5.03%	17.29%	-	-
Enterprise Value (EV) ¹	27,464	31,008	51,598	49,619	52,517	48,367	44,540
Change	-	12.91%	66.4%	-3.84%	5.84%	-7.9%	-7.91%
P/E	13.5x	14.2x	13x	13.4x	10.8x	10.7x	11.3x
PBR	1.24x	1.47x	1.64x	1.72x	1.72x	1.55x	1.41x
PEG	-	0.7x	0.3x	8.5x	0.3x	6.83x	-2.01x
Capitalization / Revenue	1.39x	1.59x	1.79x	1.68x	1.87x	1.85x	1.9x
EV / Revenue	1.51x	1.56x	2.34x	2.01x	2.03x	1.85x	1.74x
EV / EBITDA	5.89x	5.49x	8.13x	6.3x	6.42x	5.91x	5.74x
EV / EBIT	9.63x	9.71x	15.8x	9.41x	8.58x	7.73x	7.55x
EV / FCF	10.2x	8.66x	18.7x	10.2x	8.94x	7.93x	7.97x
FCF Yield	9.83%	11.5%	5.35%	9.8%	11.2%	12.6%	12.5%
Dividend per Share ²	0.58	0.7	0.95	1.15	1.566	1.406	1.521
Rate of return	2.23%	2.14%	2.3%	2.66%	3.16%	2.84%	3.07%
EPS ²	1.93	2.31	3.17	3.22	4.577	4.649	4.388
Distribution rate	30.1%	30.3%	30%	35.7%	34.2%	30.2%	34.7%
Net sales ¹	18,246	19,912	22,004	24,630	25,921	26,195	25,573
EBITDA ¹	4,663	5,652	6,347	7,881	8,182	8,191	7,765
EBIT ¹	2,852	3,195	3,270	5,275	6,120	6,261	5,899
Net income ¹	1,916	2,290	3,143	3,192	4,603	4,649	4,308
Net Debt ¹	2,031	-711	12,182	8,221	3,962	-187.5	-4,015
Reference price ²	26.05	32.76	41.32	43.16	49.52	49.52	49.52
Nbr of stocks (in thousands)	9,92,840	9,92,840	9,92,011	9,91,227	9,91,227	-	-
Announcement Date	07/02/23	07/02/24	05/02/25	04/02/26	-	-	-

¹DKK in Million²DKK

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	36.67x	13.07x	27.74x	0.54%	1,13300Cr
JOHNSON & JOHNSON	37.73x	6.36x	17.89x	2.07%	62TCr
ABBVIE INC.	36.35x	8.36x	17.26x	2.41%	50TCr
ROCHE HOLDING AG	21.21x	5.12x	12.74x	2.55%	38TCr
MERCK & CO., INC.	109.25x	6.09x	26.14x	2.27%	37TCr
NOVARTIS AG	21.57x	5.62x	13.82x	2.84%	29TCr
ASTRAZENECA PLC	22.08x	4.46x	12.77x	1.98%	26TCr
AMGEN INC.	27.83x	7.14x	12.79x	2.3%	24TCr
GILEAD SCIENCES, INC.	-44.76x	6.88x	26.67x	2.15%	19TCr
Average	29.77x	7.01x	18.64x	2.12%	44.31TCr
Weighted average by Cap.	35.57x	8.27x	20.36x	1.81%